Distribution analysis of deacetylase SIRT1 in rodent and human nervous systems

Anatomical Record

Volumn 293, Issue 6, 2010, Pages 1024-1032

  Zakhary, Sherry M ^a   Ayubcha, Diana ^a   Dileo, Jeffery N ^a   Jose, Riya ^a   Leheste, Joerg R ^a   Horowitz, Judith M ^b   Torres, German ^a  

^a NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

^b MEDAILLE COLLEGE   (United States)

Author keywords

Basal ganglia; Hippocampus; Parvalbumin; Prefrontal cortex; Tyrosine hydroxylase

Indexed keywords

ENZYME ANTIBODY; SIRTUIN 1;

ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; MOUSE; NERVE CELL; NERVOUS SYSTEM; NONHUMAN; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SPINAL CORD; WESTERN BLOTTING;

ADULT; AGING; ANIMALS; BRAIN; CELL LINE; HUMANS; MALE; MICE; MICE, INBRED C57BL; NEURODEGENERATIVE DISEASES; NEURONS; RATS; RATS, LONG-EVANS; SIRTUIN 1; SPINAL CORD;

EID: 77953166978     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.21116     Document Type: Article

References (26)

1. Baur JA, Sinclair DA. 2006. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev 5:493-506.
2. Dauer W, Przedborski S. 2003. Parkinson's disease: mechanisms and models. Neuron 39:889-909.
3. Gan L, Mucke L. 2008. Paths of convergence: sirtuins in aging and neurodegeneration. Neuron 58:10-14. (Pubitemid 351467036)
4. Guarente L, Picard F. 2005. Calorie restriction-the SIR2 connection. Cell 120:473-482.
5. Horowitz JM, Goyal A, Ramdeen N, Hallas BH, Horowitz AT, Torres G. 2003. Characterization of fluoxetine plus olanzepine treatment in rats: a behavior, endocrine, and immediate early gene expression analysis. Synapse 50:353-364. (Pubitemid 37420590)
6. Jiao Y, Sun Z, Lee T, Fusco FR, Kimble TD, Meade CA, Cuthbertson S, Reiner A. 1999. A simple and sensitive antigen retrieval method for free-floating and slide-mounted tissue sections. J Neurosci Methods 39:149-162.
7. Karson M, Tang A, Milner T, Alger B. 2009. Synaptic cross talk between perisomatic-targeting interneuron classes expressing cholecystokinin and parvalbumin in hippocampus. J Neurosci 29:4140-4154.
8. Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT, Delalle I, Baur JA, Sui G, Armour SM, Puigserver P, Sinclair DA, Tsai LH. 2007. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 26:3169-3179. (Pubitemid 47057498)
9. Lee MK, Price DL. 2001. Advances in genetic models of Parkinson's disease. Clin Neurosci Res 1:456-466. (Pubitemid 33665564)
10. Li X, Zhang S, Blander G, Tse JG, Krieger M, Guarente L. 2007. SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol Cell 28:91-106. (Pubitemid 47531974)
11. Michan S, Sinclair D. 2007. Sirtuins in mammals: insights into their biological function. Biochem J 404:1-13. (Pubitemid 46788079)
12. Motta MC, Divecha N, Lemieux M, Kamel C, Chen D, Gu W, Bultsma Y, McBurney M, Guarente L. 2004. Mammalian SIRT1 represses forkhead transcription factors. Cell 116:551-563. (Pubitemid 38264432)
13. Nemoto S, Fergusson MM, Finkel T. 2005. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1 alpha. J Biol Chem 280:16456-16460. (Pubitemid 40616776)
14. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates. 2nd ed. San Diego: Academic Press.
15. Prozorovski T, Schulze-Topphoff U, Glumm R, Baumgart J, Schroter F, Ninnemann O, Siegart E, Bendix I, Brustle O, Nitsch R, Zipp F, Aktas O. 2008. Sirt1 contributes critically to the redox-dependent fate of neural progenitors. Nat Cell Biol 10:385-394.
16. Qin W, Yang T, Ho L, Zhao Z, Wang J, Chen L, Zhao W, Thiyagarajan M, MacGrogan D, Rodgers JT, Puigserver P, Sadoshima J, Deng H, Pedrini S, Gandy S, Suave AA, Pasinetti GM. 2006. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 281:21745-21754. (Pubitemid 44181878)
17. Ramadori G, Lee CE, Bookout AL, Lee S, Williams KW, Anderson J, Elmquist JK, Coppari R. 2008. Brain SIRT1: anatomical distribution and regulation by energy availability. J Neurosci 28:9989-9996.
18. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. 2005. Nutrient control of glucose homeostasis through a complex of PGC-1 alpha and SIRT1. Nature 434:113-118. (Pubitemid 40349395)
19. Taylor JP, Hardy J, Fischbeck KH. 2002. Toxic proteins in neurodegenerative disease. Science 296:1991-1994.
20. Torres G, Frisella PD, Yousuf SJ, Sarwar S, Baldinger L, Zakhary SM, Leheste JR. 2008. A ChIP-cloning approach linking SIRT1 to transcriptional modification of DNA targets. Biotechniques 44:7.
21. Torres G, Hallas BH, Lorig EN, Strauss J, Horowitz JM. 2004. Dynamic expression of molecular chaperones in structurally and functionally intact endothelial cell networks. Preclinica 2:197-203.
22. Torres G, Hallas BH, Vernace VA, Jones C, Gross KW, Horowitz JM. 2004. A neurobehavioral screening of the ckr mouse mutant: implications for an animal model of schizophrenia. Brain Res Bull 62:315-326. (Pubitemid 38058312)
23. Torres G, Lee S, Rivier C. 1992. Immunocytochemical and in situ hybridization detection of hypothalamic neuropeptides from postmortem unfixed rat brains. Neurosci Lett 146:96-100.
24. Torres G, Meeder BA, Hallas BH, Spernyak JA, Mazurchuk R, Jones C, Gross KW, Horowitz JM. 2005. Ventricular size mapping in a transgenic model of schizophrenia. Dev Brain Res 154:35-44. (Pubitemid 40023128)
25. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA. 2001. hSIR2 (SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107:149-159. (Pubitemid 33035942)
26. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW. 2004. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23:2369-2380. (Pubitemid 38954844)